Copyright
©The Author(s) 2022.
World J Clin Cases. Oct 16, 2022; 10(29): 10501-10515
Published online Oct 16, 2022. doi: 10.12998/wjcc.v10.i29.10501
Published online Oct 16, 2022. doi: 10.12998/wjcc.v10.i29.10501
Figure 2 Prognostic value of SMARCA4 in patients with hepatocellular carcinoma.
A: 2-year survival analysis, B: 5-year survival analysis, C: 10-year survival analysis.
- Citation: Zhang L, Sun T, Wu XY, Fei FM, Gao ZZ. Delineation of a SMARCA4-specific competing endogenous RNA network and its function in hepatocellular carcinoma. World J Clin Cases 2022; 10(29): 10501-10515
- URL: https://www.wjgnet.com/2307-8960/full/v10/i29/10501.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i29.10501